-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Perspective Therapeutics, Raises Price Target to $12

Benzinga·01/30/2026 18:51:00
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target from $10 to $12.